Plotkin S A
Pasteur Mérieux, Marnes-La-Coquette, France.
Pediatr Infect Dis J. 1991 Dec;10(12):979-81. doi: 10.1097/00006454-199112000-00032.
Although epidemic poliomyelitis in the United States has been eliminated, there are a number of current issues that concern the use of oral attenuated poliovirus vaccine in comparison with the new enhanced-potency inactivated vaccine. Although wild-type poliovirus is almost eradicated in developed nations, vaccine-induced polio exists, at a low but persistent rate. This article reviews the current issues and suggests a return to the Institute of Medicine's 1988 recommendations concerning combined immunization with inactivated poliovirus vaccine and oral poliovirus vaccine.
尽管美国已消除流行性脊髓灰质炎,但与新型高效灭活疫苗相比,口服减毒脊髓灰质炎病毒疫苗的使用仍存在一些当前问题。虽然野生型脊髓灰质炎病毒在发达国家几乎已被根除,但疫苗诱导的脊髓灰质炎仍然存在,发生率较低但持续存在。本文回顾了当前问题,并建议恢复医学研究所1988年关于灭活脊髓灰质炎病毒疫苗和口服脊髓灰质炎病毒疫苗联合免疫的建议。